The Director, US Obesity – Pre-Launch will support development and execution of the US pre-launch commercial and marketing strategy for Pfizer’s obesity portfolio. This role focuses on asset-level execution, translating early insights into actionable marketing plans, and ensuring alignment with cross-functional partners and global guidance. As assets progress through late‑stage development, this role will play a key part in supporting the translation of clinical data, competitive signals, and market insights into clear US commercial implications, product positioning, and early go‑to‑market readiness plans. The focus is on executional excellence and disciplined strategic thinking—connecting evidence, insights, and customer needs into actionable recommendations that support launch planning. Operating within a highly matrixed environment, the Director must navigate ambiguity, collaborate effectively across cross‑functional partners, and balance early brand‑building needs with near‑term launch milestones. This role is essential in ensuring that US launch plans are well‑aligned, insight‑driven, and designed to position Pfizer’s obesity assets for commercial impact in the US market.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director